---
document_datetime: 2025-01-21 18:07:46
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/dabigatran-etexilate-teva-epar-all-authorised-presentations_en.pdf
document_name: dabigatran-etexilate-teva-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.7092707
conversion_datetime: 2025-12-19 00:43:03.311304
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name           | Strength   | Pharmaceutical form   | Route of administration   | Immediate packaging       | Pack size                    |
|------------------|---------------------------|------------|-----------------------|---------------------------|---------------------------|------------------------------|
| EU/1/23/1769/001 | Dabigatran Etexilate Teva | 75 mg      | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 10 capsules                  |
| EU/1/23/1769/002 | Dabigatran Etexilate Teva | 75 mg      | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 10 x 1 capsules (unit dose)  |
| EU/1/23/1769/003 | Dabigatran Etexilate Teva | 75 mg      | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 30 capsules                  |
| EU/1/23/1769/004 | Dabigatran Etexilate Teva | 75 mg      | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 30 x 1 capsules (unit dose)  |
| EU/1/23/1769/005 | Dabigatran Etexilate Teva | 75 mg      | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 60 capsules                  |
| EU/1/23/1769/006 | Dabigatran Etexilate Teva | 75 mg      | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 60 x 1 capsules (unit dose)  |
| EU/1/23/1769/007 | Dabigatran Etexilate Teva | 110 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 10 capsules                  |
| EU/1/23/1769/008 | Dabigatran Etexilate Teva | 110 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 10 x 1 capsules (unit dose)  |
| EU/1/23/1769/009 | Dabigatran Etexilate Teva | 110 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 30 capsules                  |
| EU/1/23/1769/010 | Dabigatran Etexilate Teva | 110 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 30 x 1 capsules (unit dose)  |
| EU/1/23/1769/011 | Dabigatran Etexilate Teva | 110 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 60 capsules                  |
| EU/1/23/1769/012 | Dabigatran Etexilate Teva | 110 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 60 x 1 capsules (unit dose)  |
| EU/1/23/1769/013 | Dabigatran Etexilate Teva | 110 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 100 x 1 capsules (unit dose) |
| EU/1/23/1769/014 | Dabigatran Etexilate Teva | 110 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 180 capsules                 |
| EU/1/23/1769/015 | Dabigatran Etexilate Teva | 110 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 180 x 1 capsules (unit dose) |
| EU/1/23/1769/016 | Dabigatran Etexilate Teva | 150 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 10 x 1 capsules (unit dose)  |
| EU/1/23/1769/017 | Dabigatran Etexilate Teva | 150 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 30 capsules                  |
| EU/1/23/1769/018 | Dabigatran Etexilate Teva | 150 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 30 x 1 capsules (unit dose)  |
| EU/1/23/1769/019 | Dabigatran Etexilate Teva | 150 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 60 capsules                  |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name           | Strength   | Pharmaceutical form   | Route of administration   | Immediate packaging       | Pack size                    |
|------------------|---------------------------|------------|-----------------------|---------------------------|---------------------------|------------------------------|
| EU/1/23/1769/020 | Dabigatran Etexilate Teva | 150 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 60 x 1 capsules (unit dose)  |
| EU/1/23/1769/021 | Dabigatran Etexilate Teva | 150 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 100 x 1 capsules (unit dose) |
| EU/1/23/1769/022 | Dabigatran Etexilate Teva | 150 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 180 capsules                 |
| EU/1/23/1769/023 | Dabigatran Etexilate Teva | 150 mg     | Capsule, hard         | Oral use                  | blister (OPA/alu/PVC/alu) | 180 x 1 capsules (unit dose) |